As PD is primarily a synucleinopathy and PSP a tauopathy, we also compared the alterations in CX3CL1, microglia, and CD4+ T cells in both neurodegenerative diseases to determine whether there is a difference between pathologies. This evidence concerns the gene CX3CL1 and Parkinson disease.